Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.9 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |